Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by BMO Capital Markets from $156.00 to $139.00 in a report ...

Informatica (NYSE:INFA) shares tumbled around 35% premarket on Friday after the data management company was hit with a string of downgrades following its weak quarterly results. Baird downgraded ...

RBC Capital analyst Gregory Renza maintained a Buy rating on IDEAYA Biosciences (IDYA – Research Report) yesterday and set a price target of ...

In a report released yesterday, Shagun Singh Chadha from RBC Capital reiterated a Buy rating on Dexcom (DXCM – Research Report), with a price ...

European miners are scheduled to report fourth-quarter and full-year results over the next four weeks. Gold prices are trading near record highs as investors turn to safe haven assets as economic and ...

State of Alaska Department of Revenue lifted its position in RBC Bearings Incorporated (NYSE:RBC – Free Report) by 5.8% in ...

Following a record year for catastrophe bond issuance in 2024, the cat bond market remains strong, and according to analysts ...

Brighthouse posted very strong Q4 earnings of $5.88 per share, beating the Zacks Consensus Estimate of $4.44 per share.